Allogene Therapeutics (ALLO) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Allogene Therapeutics (ALLO) over the last 7 years, with Q3 2025 value amounting to $104.5 million.
- Allogene Therapeutics' Other Gross PP&E Adjustments fell 2315.59% to $104.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.5 million, marking a year-over-year decrease of 2315.59%. This contributed to the annual value of $81.5 million for FY2024, which is 3253.02% up from last year.
- As of Q3 2025, Allogene Therapeutics' Other Gross PP&E Adjustments stood at $104.5 million, which was down 2315.59% from $103.9 million recorded in Q2 2025.
- Allogene Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $140.9 million for Q2 2024, and its period low was $40.4 million during Q4 2022.
- In the last 5 years, Allogene Therapeutics' Other Gross PP&E Adjustments had a median value of $86.1 million in 2024 and averaged $87.6 million.
- Per our database at Business Quant, Allogene Therapeutics' Other Gross PP&E Adjustments tumbled by 4512.82% in 2022 and then skyrocketed by 10103.84% in 2024.
- Quarter analysis of 5 years shows Allogene Therapeutics' Other Gross PP&E Adjustments stood at $73.6 million in 2021, then tumbled by 45.13% to $40.4 million in 2022, then surged by 52.25% to $61.5 million in 2023, then skyrocketed by 32.53% to $81.5 million in 2024, then rose by 28.16% to $104.5 million in 2025.
- Its Other Gross PP&E Adjustments was $104.5 million in Q3 2025, compared to $103.9 million in Q2 2025 and $104.6 million in Q1 2025.